Revance Replaces Lidocaine with Mepivacaine in RHA Filler Line
Revance announces the U.S. launch of the Teoxane RHA Collection with mepivacaine, replacing lidocaine as the anesthetic in its dermal filler products.
Revance announces the U.S. launch of the Teoxane RHA Collection with mepivacaine, replacing lidocaine as the anesthetic in its dermal filler products.
The professional-exclusive serum and cream use epidermal growth factor and amino acids to support skin barrier repair, with small clinical studies reporting improvements in redness, hydration, and recovery following aesthetic procedures.